CNBC International TV
24 Jul 2026, 06:31 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
The Trump administration plans to increase generic drug import tariffs to 100% by 2030. — Such a drastic increase in tariffs would significantly raise costs and disrupt supply chains for generic drug manufacturers.
-0.80Dr. Reddy's Laboratories has temporarily halted production of Semaglutide due to an impurity issue. — Production halts of a high-demand drug like Semaglutide lead to immediate revenue loss and potential regulatory scrutiny.
-0.50Which stocks this story touches
The company faces a production halt for Semaglutide due to impurities and potential headwinds from proposed import tariffs.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
WSJ
22m ago
